VINCI and ACS sign final agreement for the acquisition of Cobra IS
VINCAugust 8, 2025Mergers
Read more →Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal
VINCFailure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholders Failure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholders
June 18, 2025Dissolution
Read more →Vincerx Pharma Q1 EPS $(1.40) Up From $(11.60) YoY
VINCMay 15, 2025
Read more →Trading Halt: Halt status updated at 4:30:00 PM ET: Quotation Resumption: News and Resumption Times
VINCApril 8, 2025
Read more →Vincerx Pharma Announces That It Has Terminated Previously Announced Non-Binding Letter Of Intent With Global Digital Holdings Regarding a Potential Merger
VINCApril 8, 2025
Read more →Trading Halt: Halted at 4:01:00 p.m. ET - Trading Halt: Halt News Pending
VINCApril 8, 2025
Read more →Vincerx Pharma Enters Non-Binding LOI With QumulusAI For Reverse Merger; QumulusAI To Own 95% Of Combined Entity Valued At $285M, Vincerx At $15M; QumulusAI Or Its Designees Will Invest Up To $1.5M In The Equity Of Vincerx Prior To Closing
VINCMarch 18, 2025
Read more →Trading Halt: Halt status updated at 4:30:00 PM ET: Quotation Resumption: News and Resumption Times
VINCFebruary 28, 2025
Read more →Vincerx Pharma Board To Reassess Strategic Alternatives Including Out-Licensing, Merger And Acquisition Opportunities, The Sale Of Assets And Technologies And Winding Down Operations Among Other Potential Transactions
VINCFebruary 28, 2025
Read more →Vincerx Pharma Announces Termination Of Term Sheet Between Vincerx, Oqory And Vivasor For Reverse Merger Transaction
VINCFebruary 28, 2025
Read more →Trading Halt: Halted at 4:00:10 p.m. ET - Trading Halt: Halt News Pending
VINCFebruary 28, 2025
Read more →